More from HEALTH!
Picture someone in their late seventies whose steps have shrunk to a shuffle, who's begun to lean on furniture, and whose family has quietly filed it all under old age. Sometimes that's not aging at all. In a trial of… Read More →
HEALTH
Understand or prevent a condition.
-
-
A Shorter, Focused Radiation Course Held Its Own Against Standard Radiotherapy in Early Prostate Cancer
Five sessions of precisely targeted radiation controlled early prostate cancer as well as conventional courses of 20 to 39 sessions. At five years, 95.8% of men treated with the short course were free of any sign that the cancer had… Read More →
-
Women With High-Risk Early Breast Cancer Lived Longer After Adding Abemaciclib
Two years of the targeted pill abemaciclib, added to standard hormone therapy, lowered the relative risk of death by 15.8% in high-risk early breast cancer, in the final survival results of a 5,637-patient randomized trial. That relative figure compares death… Read More →
-
Infants Given a New Antibody Shot Were Hospitalized for RSV Far Less Often
One injection of clesrovimab, a laboratory-made antibody against respiratory syncytial virus, cut medically attended RSV lung infections by 60.4% and RSV hospitalizations by 84.2% among 3,614 healthy infants going through their first RSV season. The raw counts run like this.… Read More →
-
Baxdrostat Lowered Blood Pressure That Resisted Standard Treatment
A once-daily pill from a drug class that did not exist in pharmacies lowered systolic blood pressure about 9 to 10 points further than placebo, in adults whose readings stayed high on two, three or more medicines. The drug is… Read More →
-
Adding Darolutamide to Hormone Therapy Delayed Advanced Prostate Cancer’s Progression
A man whose prostate cancer has spread usually starts on hormone therapy that strips away most of his testosterone, and for a while the cancer stalls. Adding a second drug, the pill darolutamide, cut the risk of cancer progression or… Read More →
-
Silver Diamine Fluoride Halted More Cavities Than Placebo in Young Children
A liquid brushed painlessly onto a cavity stopped the decay in 50.2% of treated baby teeth after eight months, against 17.4% of teeth that received a placebo, in a randomized trial of 830 young children. The liquid is silver diamine… Read More →
-
Semaglutide Did Not Slow Early Alzheimer’s Disease
Two years of daily semaglutide did nothing to slow early Alzheimer's disease. People on the drug and people on a placebo declined by almost exactly the same amount: about two points on an 18-point dementia staging scale. The difference between… Read More →